Quadrature Capital Ltd Buys New Stake in Ardent Health Partners, LLC (NYSE:ARDT)

Quadrature Capital Ltd purchased a new stake in Ardent Health Partners, LLC (NYSE:ARDT) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor purchased 12,474 shares of the company’s stock, valued at approximately $229,000.

Other hedge funds also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets purchased a new stake in shares of Ardent Health Partners in the third quarter worth about $42,000. Financial Management Professionals Inc. acquired a new stake in Ardent Health Partners in the third quarter valued at approximately $50,000. MetLife Investment Management LLC purchased a new stake in shares of Ardent Health Partners during the third quarter valued at approximately $135,000. Centiva Capital LP acquired a new position in shares of Ardent Health Partners during the third quarter worth $469,000. Finally, Charles Schwab Investment Management Inc. purchased a new position in shares of Ardent Health Partners in the third quarter valued at $526,000.

Ardent Health Partners Trading Up 1.0 %

ARDT stock opened at $16.68 on Wednesday. Ardent Health Partners, LLC has a 1-year low of $14.57 and a 1-year high of $20.72. The company’s fifty day simple moving average is $17.50. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on ARDT. Stephens reaffirmed an “overweight” rating and set a $24.00 price target on shares of Ardent Health Partners in a research note on Thursday, September 19th. Bank of America cut Ardent Health Partners from a “buy” rating to a “neutral” rating and cut their price target for the stock from $22.00 to $19.00 in a research note on Wednesday, November 6th. Leerink Partners lifted their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a report on Tuesday, November 12th. KeyCorp started coverage on Ardent Health Partners in a research report on Friday, October 11th. They issued an “overweight” rating and a $24.00 target price on the stock. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $23.00 price target on shares of Ardent Health Partners in a research report on Thursday, November 14th. Two research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $21.82.

Ardent Health Partners Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.